Emergence of simian foamy viruses in humans: Facts and unanswered questions

Future Virology

Volumn 3, Issue 1, 2008, Pages 71-81

  Gessain, Antoine ^a   Calattini, Sara ^a,b  

^a CNRS   (France)

^b Department of Transfusion Medicine   (United States)

Author keywords

Emerging viruses; Epidemiology; Foamy; Hunters; Interspecies transmission; Primates; Retrovirus; Zoonosis

Indexed keywords

AFRICA; APE; DISEASE ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS 1; MOLECULAR PHYLOGENY; MONKEY; NONHUMAN; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PRIMATE; PRIORITY JOURNAL; PUBLIC HEALTH; RADIOIMMUNOPRECIPITATION; RETROVIRUS; REVIEW; SERODIAGNOSIS; SPUMA VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS TRANSMISSION; VIRUS VIRULENCE; WESTERN BLOTTING;

ANIMALIA; HUMAN FOAMY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; PRIMATES; SIMIAE; SIMIAN FOAMY VIRUS; SPUMARETROVIRINAE; SPUMAVIRUS;

EID: 38049144846     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460794.3.1.71     Document Type: Review

References (57)

1. Weiss RA, McMichael AJ: Social and environmental risk factors in the emergence of infectious diseases. Nat. Med. 10. S70-S76 (2004).
2. Kruse H, Kirkemo AM, Handeland K: Wildlife as source of zoonotic infections. Emerg. Infect. Dis. 10, 2067-2072 (2004).
3. Halpin K, Hyatt AD, Plowright RK et al.: Emerging viruses: coming in on a wrinkled wing and a prayer. Clin. Infect. Dis. 44, 711-717 (2007).
4. Peeters M, Courgnaud V, Abela B et al.: Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. Emerg. Infect. Dis. 8, 451-457 (2002).
5. Wolfe ND, Dunavan CP, Diamond J: Origins of major human infectious diseases. Nature 447, 279-283 (2007).
6. Wolfe ND: Bushmeat hunting, deforestation, and prediction of zoonotic disease emergence. Emery Infect. Dis. 11, 1822-1827 (2005).
7. Schillaci MA, Jones-Engel L, Engel GA et al.: Prevalence of enzootic simian viruses among urban performance monkeys in Indonesia. Top. Med. Int. Health 10, 1305-1314 (2005).
8. Apetrei C, Marx PA: Simian retroviral infections in human beings. Lancet 364, 137-138; author reply 139-140 (2004).
9. Wolfe N, Switzer WM, Heneine W: Emergence of novel retrovirus. In: Emerging Infections. Sheld W, DC H, Hughs J (Eds). 139-153 (2007).
10. Weiss PA: Retroviral zoonoses. Nat. Med. 4, 391-392 (1998).
11. Van Heuverswyn F, Peeters M: The origins of HIV and implications for the global epidemic. Curr. Infect. Dis. Rep. 9, 338-346 (2007).
12. Hahn BH, Shaw GM, De Cock KM, Sharp PM: AIDS as a zoonosis: scientific and public health implications. Science 287, 607-6014 (2000).
13. Mahieux R. Ibrahim F, Mauclere P et al.: Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in pygmies. J. Vicol.. 71, 1317-1333 (1997).
14. Slattery JP, Franchini G, Gessain A: Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res. 9, 525-540 (1999).
15. Metering CD, Linial ML: Historical perspective of foamy virus epidemiology and infection. Clin. Microbiol. Rev. 14, 165-176 (2001).
16. Delelis O, Lehmann-Che J, Saib A: Foamy viruses - a world apart. Curr. Opin. Microbiol. 7, 400-406 (2004).
17. Murray SM, Linial ML: Foamy virus infection in primates. J. Med. Primatol. 35, 225-235 (2006).
18. Enders JF, Peebles TC: Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc. Soc. Exp. Biol. Med. 86, 277-286 (1954).
19. Saib A: Non-primate foamy viruses. Curr. Top. Microbiol. Immunol. 277, 197-211 (2003).
20. Bastone P, Truyen U, Lochelt M: Potential of zoonotic transmission of non-primate foamy viruses to humans. J. Vet. Med. B Infect. Dis. Vet. Public Health 50, 417-423 (2003).
21. Blewett EL, Black DH, Lerche NW, White G, Eberle R: Simian foamy virus infections in a baboon breeding colony. Virology 278, 183-193 (2000).
22. Broussard SR, Comuzzie AG, Leighton KL, Leland MM, Whitehead EM, Allan JS: Characterization of new simian foamy viruses from African nonhuman primates. Pirology 237, 349-359 (1997).
23. Hussain AI. Shanmugam V, Bhullar VB et al.: Screening for simian foamy virus infection by using a combined antigen Western blot assay: evidence for a wide distribution among Old World primates and identification of four new divergent viruses. Virology 309, 248-257 (2003).
24. Calattini S, Wanert F, Thierry B et al.: Modes of transmission and genetic diversity of foamy viruses in a Macaca Tonkeana colony. Retrovirology 3, 23 (2006).
25. Jones-Engel L, Engel GA, Schillaci MA et al. Primate-to-human retroviral transmission in Asia. Emerg. Infect. Dis. 11, 1028-1035 (2005).
26. Jones-Engel L, Steinkraus KA, Murray SM et al.: Sensitive assays for simian foamy viruses reveal a high prevalence of infection in commensal, free-ranging Asian monkeys. J. Virol. 81, 7330-7337 (2007).
27. Falcone V, Leopold J, Clotten J et al.: Sites of simian foamy virus persistence in naturally infected African green monkeys: latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology 257, 7-14 (1999).
28. Falcone V. Schweizer M, Neumann-Haefelin D: Replication of primate foamy viruses in natural and experimental hosts. Curr. Top. Microbiol. Immunol. 277, 161-180 (2003).
29. Murray SM, Picker LJ, Axtheim MK, Linial ML: Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J. Virol. 80, 663-670 (2006). 30 Linial M: Why arerh foamy viruses pathogenic? Trends Microbiol. 8, 284-289 (2000).
30. Schweizer M, Neumann-Haefelin D: Phylogenetic analysis of primate foamy viruses by comparison of Pol sequences. Virology 207, 577-82 (1995).
31. Schweizer M, Schleer H, Pietrek M, Liegibel J, Falcone V, Neumann-Haefelin D: Genetic stability of foamy viruses: long-term study in an African green monkey population. J. Virol. 73, 9256-9265 (1999).
32. Switzer WM, Salemi M, Shanmugam V et al.: Ancient co-speciation of simian foamy viruses and primates. Nature 434, 376-380 (2005).
33. Achong BG, Mansell PW, Epstein MA, Clifford P: An unusual virus in cultures from a human nasopharyngeal carcinoma. J. Natl. Cancer Inst. 46, 299-307 (1971).
34. Epstein MA: Simian retroviral infections in human beings. Lancet 364, 138-139; author reply 139-140 (2004).
35. Switzer WM, Bhullar V, Shanmugam V et al.: Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J. Virol. 78, 2780-2789 (2004).
36. Heneine W, Schweizer M, Sandstrom P, Folks T: Human infection with foamy viruses. Curr. Top. Microbiol. Immunol. 277, 181-196 (2003).
37. Schweizer M, Turek R, Hahn H et al.: Markers of foamy virus infections in monkeys. apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res. Hum. Retroviruses 11, 161-170 (1995).
38. Hooks JJ, Gibbs CJ Jr: The foamy viruses. Bacteriol. Rev. 39, 169-185 (1975).
39. Kalter SS, Heberling RL: Comparative virology of primates. Bacteriol. Rev. 35, 310-364 (1971).
40. Schweizer M, Falcone V, Gange J, Turek R, Neumann-Haefelin D: Simian foamy virus isolated from an accidentally infected human individual. J. Virol. 71, 4821-4824 (1997).
41. Heneine W, Switzer WM, Sandstrom P et al.: Identification of a human population infected with simian foamy viruses. Nat. Med. 4, 403-407 (1998).
42. Sandstrom PA, Phan KO, Switzer WM et al.: Simian foamy virus infection among zoo keepers. Lancet 355, 551-2 (2000).
43. Brooks JI, Rud EW, Pilon RG, Smith JM, Switzer WM, Sandstrom PA: Cross-species retroviral transmission from macaques to human beings. Lancet 360, 387-388 (2002).
44. Lerche NW, Switzer WM, Yee JL et al.: Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates. J. Virol. 75, 1783-1789 (2001).
45. Wolfe ND, Switzer WM, Carr JK et al.: Naturally acquired simian retrovirus infections in Central African hunters. Lancet 363, 932-937 (2004).
46. Calattini S, Betsem A, Betsem E et al.: Simian foamy virus transmission from apes to humans, rural Cameroon. Emerging Infect. Dis. 13, 1314-1320 (2007).
47. Calattini S, Nerrienet E, Mauclere P, Georges-Courbot MC, Saib A, Gessain A: Detection and molecular characterization of foamy viruses in Central African chimpanzees of the Pan troglodytes troglodytes and Pan troglodytes vellerosus subspecies. J. Med. Primatol. 35, 59-66 (2006).
48. Calattini S, Nerrienet E, Mauclere P, George-Courbot MC, Saib A. Gessain A: Natural simian foamy virus infection in wild-caught gorillas, mandrills and drills from Cameroon and Gabon. J. Gen. Virol. 85, 3313-3317 (2004).
49. Brashares JS, Arcese P, Sam MK, Coppolillo PB, Sinclair AR, Balmford A: Bushmeat hunting, wildlife declines, and fish supply in West Africa. Science 306, 1180-1183 (2004).
50. Engel G, Hungerford LL, Jones-Engel L et al.: Risk assessment: a model for predicting cross-species transmission of simian foamy virus from macaques (M. fascicularis) to humans at a monkey temple in Bali, Indonesia. Am. J. Primatol. 68, 934-948 (2006).
51. Verdonck K, Gonzalez E. Van Dooren S. Vandamme AM, Vanham G, Gotuzzo E: Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect. Dis. 7, 266-281 (2007).
52. Mosoko JJ, Macauley IB, Zoungkanyi AC, Bella A, Koulla-Shiro, S: Human immunodeficiency virus infection and associated factors among specific population subgroups in Cameroon. AIDS Behav. doi: 10.1007/ s10461-007-9294-8 (2007) (Epub ahead of print).
53. Brooks JI, Merks HW, Fournier J, Boneva RS, Sandstrom PA: Characterization of blood-borne transmission of simian foamy virus. Transfusion 47, 162-170 (2007).
54. Khan AS, Kumar D: Simian foamy virus infection by whole-blood transfer in rhesus macaques: potential for transfusion transmission in humans. Transfusion 46. 1352-1359 (2006).
55. Delebecque F, Suspene R, Calattini S et al.: Restriction of foamy viruses by APOBEC cytidine deaminases. J. Virol. 80, 605-614 (2006).
56. Holmes RK, Malim MH, Bishop KN: APOBEC-mediated viral restriction: not simply editing? Trends Biochem. Sci. 32, 118-128 (2007).
57. Towers G: Restriction of retroviruses by TRIM5α. Future Virology 1, 71-78 (2006).